Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Pharmacogenomics|November 15, 2012
Building bridges to the future of medicine: recommendations for boosting development of novel and companion diagnosticsJames CreedenAutoimmune Diseases|September 15, 2011
A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisPeter Taylor, Juliane Gartemann, Jeanie Hsieh, et al.Molecular Diagnosis & Therapy|July 20, 2011
Serum tests for colorectal cancer screeningJames Creeden, Frank Junker, Sabine Vogel-Ziebolz, et al.Hypertension in Pregnancy|June 4, 2013
Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspectiveNandini Hadker, Suchita Garg, Cory Costanzo, et al.Health Science Reports|August 21, 2023
Stakeholders' expectations of precision medicine: A qualitative study to identify areas of (mis)alignmentTanya Knott, James Creeden, Benjamin Horbach, et al.Journal of Medical Economics|December 9, 2010
Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspectiveNandini Hadker, Suchita Garg, Cory Costanzo, et al.The AAPS Journal|October 15, 2020
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint InhibitorsOle Gjoerup, Charlotte A Brown, Jeffrey S Ross, et al.Cancer Research Communications|March 16, 2023
Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal CancerRyon P Graf, Virginia Fisher, James Creeden, et al.Journal for Immunotherapy of Cancer|June 16, 2021
Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expressionRichard S P Huang, Brennan Decker, Karthikeyan Murugesan, et al.The Oncologist|September 8, 2023
Insights of Clinical Significance From 109 695 Solid Tumor Tissue-Based Comprehensive Genomic ProfilesAndreas M Heilmann, Jonathan W Riess, Margaret McLaughlin-Drubin, et al.Pageof 3